34 articles
A.G.W. Whitfield
A.G.W. Whitfield (Allan George Williams Whitfield, 1909–1987) was a British physician and professor of medicine at Birmingham, known for research on lung volume and radiation lung damage.
Àlvar Agustí
Àlvar Agustí (Alvar Agustí García-Navarro), born in Barcelona in 1956, is a Spanish pulmonologist and COPD researcher, professor at the Universitat de Barcelona and chair of the global COPD initiative GOLD since 2016.
Bartolomé R. Celli
Bartolomé R. Celli is a Venezuelan-trained pulmonary physician and Professor of Medicine at Harvard Medical School, known for the BODE index and co-chairing ATS/ERS COPD guidelines.
Benjamin Burrows
Benjamin Burrows (1927–2002) was an American pulmonary physician-scientist at the University of Arizona in Tucson, known for epidemiological research on COPD and obstructive airway disease.
Claus Vogelmeier
Claus Vogelmeier (born 1956) is a German pulmonologist at Marburg who led the POET-COPD trial, helped lead FLAME, and has chaired the GOLD COPD strategy since 2014.
Dave Singh
Dave Singh is a British respiratory physician-scientist, Professor at the University of Manchester since 2011 and Medical Director of the Medicines Evaluation Unit, known for leading major COPD drug trials.
Denis E. O’Donnell
Denis E. O'Donnell is a Canadian respirologist and Professor of Medicine (Emeritus) at Queen's University who founded the Respiratory Investigation Unit and studies breathlessness and exercise limitation in COPD.
Dennis E. Niewoehner
Dennis E. Niewoehner was an American pulmonary physician and COPD researcher who spent 42 years as Chief of the Pulmonary Section at the Minneapolis VA Medical Center.
Don D. Sin
Don D. Sin (Don Sin) is a Canadian respirologist known for research linking COPD to systemic inflammation and cardiovascular disease, and Director of the Centre for Heart Lung Innovation at the University of British Columbia.
Donald P. Tashkin
Donald P. Tashkin is an American pulmonologist and Distinguished Emeritus Professor at UCLA, known for the UPLIFT COPD trial, the Scleroderma Lung Study, and decades of research on marijuana smoking and the lungs.
Fernando J. Martínez
Fernando J. Martínez is a Cuban-born pulmonary physician-scientist known for research on COPD and interstitial lung disease, and editor-in-chief of the American Journal of Respiratory and Critical Care Medicine.
Frank C. Sciurba
Frank C. Sciurba, also known as Frank Sciurba, is an American pulmonologist and COPD researcher who directs the Emphysema COPD Research Center at the University of Pittsburgh.
Gerard J. Criner
Gerard J. Criner is an American pulmonologist, founding chair of Thoracic Medicine and Surgery at Temple University, known for leading COPD trials including STATCOPE and benralizumab studies.
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha, born 1953, is a British respiratory physician and professor at Imperial College London known for research on COPD exacerbations and for leading the FLAME trial.
James C. Hogg
James C. Hogg is a Canadian pulmonary pathologist at the University of British Columbia whose work established the small airways as the site of obstruction in COPD.
John Britton (respiratory physician)
John Richard Britton, born 1955, is a British respiratory physician and epidemiologist at the University of Nottingham who founded the UK Centre for Tobacco and Alcohol Studies.
Jørgen Vestbo
Jørgen Vestbo is a Danish respiratory physician and Emeritus Professor at the University of Manchester known for research on COPD, including the 2015 lung-function trajectories study.
Klaus F. Rabe
Klaus F. Rabe (born 1957) is a German pulmonologist and professor of pulmonary medicine at Kiel, known for the ETHOS COPD trial and dupilumab severe asthma trial.
Leonardo M. Fabbri
Leonardo M. Fabbri is an Italian respiratory physician, Eminent Scholar at the University of Ferrara, who established COPD's inflammatory character and helped found the GOLD guidelines.
Marc Decramer
Marc Decramer (1953–2026) was a Belgian pulmonologist and professor at KU Leuven who led the 2008 four-year tiotropium trial in COPD, chaired the GOLD initiative, and served as CEO of UZ Leuven.
Mark T. Dransfield
Mark T. Dransfield, also cited as Mark Dransfield, is an American pulmonologist at the University of Alabama at Birmingham, chair of its Department of Medicine since 2025, known for COPD exacerbation research.
MeiLan K. Han
MeiLan K. Han is an American pulmonologist and clinical researcher who is Chief of Pulmonary and Critical Care at the University of Michigan, known for COPD research.
Peter J. Barnes
Peter J. Barnes, known in the literature as P. J. Barnes, is a British respiratory pharmacologist and Professor of Thoracic Medicine at Imperial College London, known for work on asthma and COPD.
Peter M.A. Calverley
Peter M.A. Calverley, born 1949, is a British pulmonologist and Emeritus Professor of Respir Medicine at Liverpool, known for the TORCH and TIOSPIR COPD trials.
Peter T. Macklem
Peter T. Macklem (1931–2011) was a Canadian respiratory physician-scientist at McGill University in Montreal, known for work on small airways disease and respiratory muscle fatigue.
Prescott G. Woodruff
Prescott G. Woodruff is an American pulmonologist and physician-scientist who is chief of the pulmonary division at UCSF, known for research on molecular sub-phenotypes of asthma and COPD.
R. Graham Barr
R. Graham Barr is a Scottish-born respiratory epidemiologist at Columbia University, where he is Chief of General Medicine and leads the MESA Lung Study, a long-running CT study of emphysema.
Richard Casaburi
Richard Casaburi is an American physician-scientist in pulmonary medicine who directs the Rehabilitation Clinical Trials Center at Harbor-UCLA and established exercise training and anabolic therapy as treatments for COPD.
Roger Goldstein
Roger S. Goldstein is a respirologist at West Park Healthcare Centre and professor at the University of Toronto whose trials and 1996 Lancet meta-analysis established pulmonary rehabilitation as evidence-based care in COPD.
Ronald G. Crystal
Ronald G. Crystal is an American physician-scientist in pulmonary medicine and gene therapy who developed the FDA-approved therapy for alpha-1 antitrypsin deficiency and pioneered human adenovirus gene transfer.